Moreover, a statistically significant increase in the percentage and absolute number of CD4+ CD20+ follicular helper T (CXCR5+, TFH) cells was detected in CLL patients compared to the control group (Figures 3B, 4B). This evidence concerns the gene CXCR5 and B-cell chronic lymphocytic leukemia.